Hypersensitivity and Acute myeloid leukaemia

Summary:

Acute myeloid leukaemia is found among people with Hypersensitivity, especially for people who are female, 60+ old.

The study analyzes which people have Acute myeloid leukaemia with Hypersensitivity. It is created by eHealthMe based on reports of 31 people who have Hypersensitivity from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,750 drugs and 2,913 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

What is Acute myeloid leukaemia?

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts) is found to be associated with 721 drugs and 1,223 conditions by eHealthMe. Check the latest studies of Acute myeloid leukaemia.



On Jul, 20, 2026

31 people who have Hypersensitivity and Acute Myeloid Leukaemia are studied.

Would you have Acute myeloid leukaemia when you have Hypersensitivity?

Gender of people who have Hypersensitivity and experienced Acute Myeloid Leukaemia *:

  • female: 77.78 %
  • male: 22.22 %

Age of people who have Hypersensitivity and experienced Acute Myeloid Leukaemia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 4.17 %
  • 30-39: 0.0 %
  • 40-49: 29.17 %
  • 50-59: 4.17 %
  • 60+: 62.5 %

Common co-existing conditions for these people *:

  1. Asthma: 13 people, 41.94%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 35.48%
  3. High Blood Pressure: 11 people, 35.48%
  4. Depression: 10 people, 32.26%
  5. Gastric Disorder (disease of stomach): 9 people, 29.03%
  6. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 8 people, 25.81%
  7. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 8 people, 25.81%
  8. Diarrhea: 7 people, 22.58%
  9. High Blood Cholesterol: 6 people, 19.35%
  10. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 19.35%

Common drugs taken by these people *:

  1. Humira: 8 people, 25.81%
  2. Zyrtec: 7 people, 22.58%
  3. Pentasa: 7 people, 22.58%
  4. Budesonide: 7 people, 22.58%
  5. Escitalopram Oxalate: 7 people, 22.58%
  6. Lansoprazole: 7 people, 22.58%
  7. Lomotil: 7 people, 22.58%
  8. Lasix: 6 people, 19.35%
  9. Augmentin: 6 people, 19.35%
  10. Neurontin: 6 people, 19.35%

Common symptoms for these people *:

  1. Second Primary Malignancy (after getting cure a cancer, a new cancer development): 6 people, 19.35%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 16.13%
  3. Platelet Count Increased: 5 people, 16.13%
  4. Osteitis (a general term for inflammation of bone): 5 people, 16.13%
  5. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 16.13%
  6. Heart Valve Stenosis (abnormal narrowing of the aortic valve in the heart): 5 people, 16.13%
  7. Haemorrhage (bleeding): 5 people, 16.13%
  8. Haematoma (collection of blood outside the blood vessels): 5 people, 16.13%
  9. Dyspnea (difficult or laboured breathing): 5 people, 16.13%
  10. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 5 people, 16.13%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Acute myeloid leukaemia?

- Check whether Acute myeloid leukaemia is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Acute myeloid leukaemia:

All the conditions that are associated with Acute myeloid leukaemia:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Acute myeloid leukaemia and Hypersensitivity, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: